ROTHBLATT MARTINE A bought UTHR
November 17, 2025 · Form 4 insider transaction
ROTHBLATT MARTINE A bought 4,000 shares of United Therapeutics Corporation at $120.26 per share, a transaction worth $481.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
4,000
Price
$120.26
Total value
$481.0K
InsiderROTHBLATT MARTINE A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 17, 2025
Filing dateNovember 18, 2025
Shares owned after4,130
OwnershipDirect
10b5-1 planNo
AmendedNo